Proteome Sciences (LON:PRM) Stock Price Up 63% – Still a Buy?

Proteome Sciences plc (LON:PRM)’s share price rose 63% on Tuesday . The company traded as high as GBX 4.40 and last traded at GBX 4.40. Approximately 520,578 shares traded hands during mid-day trading, a decline of 33% from the average daily volume of 774,943 shares. The stock had previously closed at GBX 2.70.

Proteome Sciences Trading Up 33.6%

The stock has a market cap of £10.65 million, a PE ratio of -3.19 and a beta of 0.07. The company has a 50 day moving average of GBX 2.05 and a two-hundred day moving average of GBX 2.54. The company has a debt-to-equity ratio of -258.66, a quick ratio of 0.37 and a current ratio of 0.20.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.